Jun 19, 2020
Plakous Therapeutics Receives Rare Pediatric Disease and Orphan Drug Designations for Protego-PD(TM) for the Prevention of Necrotizing Enterocolitis
Jun 17, 2020
Hepcidin Mimetic PTG-300 Receives U.S. FDA Orphan Drug Designation for the Treatment of Polycythemia Vera
Jun 11, 2020
CNS Announces the FDA has Granted Orphan Drug Designation for Brain Cancer Drug Berubicin
Jun 03, 2020
Clarity Pharmaceuticals Announces that the US FDA Grants Rare Pediatric Disease Designation to 67Cu-SARTATE(TM) for the Treatment of Neuroblastoma
May 27, 2020
Microbion Corporation Announces Orphan Drug Designation Granted for Pravibismane Suspension for Inhalation by US FDA
May 21, 2020
Global Pharmaceutical Excipients Market to Expand as FDA Ramps up Approval of New Drug Classes, TMR
May 14, 2020
Cellphire Announces Orphan Drug Designation of Thrombosomes® for Treatment of Acute Radiation Syndrome
May 14, 2020
Nordic Nanovector's Betalutin® Receives Positive Opinion for Orphan Drug Designation from EMA for Marginal Zone Lymphoma (MZL)
May 12, 2020
Alpha Cognition Inc. Announces Granted EU Patents and Orphan Drug Designation for Its Progranulin Platform
May 06, 2020
FDA Grants MIV-818 Orphan Drug Designation for the Treatment of Hepatocellular Carcinoma
May 04, 2020
White Paper "Rare Pharmacy Emerges from Specialty (Pharmacy)" Published
Apr 27, 2020
CARsgen Therapeutics Receives Positive EMA Opinion on Orphan Drug Designation for Fully Human Anti-BCMA CAR-T Cells (CT053) for the Treatment of Multiple Myeloma
Apr 24, 2020
COVID-19 And Beyond: How FDA Commissioner Hahn Can Immediately Speed-Up Medical Discovery With A Simple Stroke Of His Pen By Creating A Two-Tier System
Apr 23, 2020
CNS Pharmaceuticals Announces Filing of FDA Orphan Drug Designation for Brain Cancer Drug Berubicin
Apr 23, 2020
U.S. FDA grants orphan drug designation to AmideBio's glucagon analog for the treatment of congenital hyperinsulinism
Apr 23, 2020
Orphan Drug Act Fueling $200 Billion Dollar Market
Apr 22, 2020
World Orphan Drugs Industry Overview 2020: Valued at $132.6 Billion in 2019
Apr 21, 2020
Clarity Pharmaceuticals Announces US FDA Grants 67Cu-SARTATE(TM) Orphan Drug Designation for Neuroblastoma
Apr 10, 2020
FDA Approves First Therapy for Children with Debilitating and Disfiguring Rare Disease
Apr 08, 2020
MMJ International Holdings Ships First-Ever Marijuana Extracts to USA